Clinical Trial Update: Evaluation of Safety, Pharmacokinetics and Efficacy of Ceftazidime and Avibactam (CAZ-AVI ) Compared With Cefepime in Children From 3 Months to Less Than 18 Years of Age With Complicated Urinary Tract Infections (cUTIs) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety, pharmacokinetics, and efficacy of ceftazidime-avibactam compared with cefepime in children aged 3 months to under 18 with compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complicated Urinary Tract Infection

Drugs mentioned

• Cefepime (cefepime)
• ceftazidime/avibactam (ceftazidime/avibactam)

Snippet

Sponsor: Pfizer | Conditions: Complicated Urinary Tract Infections | Phase 2 | Status: COMPLETED | Results posted: 2018-04-10